Recruitment and retention issues result in trial delays and costs and may potentially undermine trial results. Every clinical trial phase is facing its own specific hurdles. The fact that early phase trials do not offer therapeutic benefit for the subjects is a specific drawback.
Phase 1 trials are typically performed in healthy volunteers, whereas from phase 2 onwards patient populations are needed. However, special populations and patient cohorts are increasingly included early on.
Please download this free white paper to read more.